Boundless Bio, Inc.

Boundless Bio, Inc.

BOLD · Nasdaq

Boundless Bio, Inc. (BOLD) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Boundless Bio, Inc. in 2026. The next earnings report is expected on November 5, 2026.

Earnings calendar

Next earnings date

05 Nov 2026

In 78 days

EPS estimate

-0.56

Revenue estimate

0

Past earnings

07 Aug 2026
EPS actual
—
estimate -1.06
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
18 May 2026
EPS actual
—
estimate -0.58
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
26 Mar 2026
EPS actual
-0.58 (-11.5%)
estimate -0.52
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
09 Mar 2026
EPS actual
-0.58 (-11.5%)
estimate -0.52
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Zachary Hornby
Employees
64
IPO date
20 Jul 2016
ISIN
US10170A1007
Website
boundlessbio.com

Frequently asked questions

When does Boundless Bio, Inc. (BOLD) next report earnings?

Boundless Bio, Inc. (BOLD) is scheduled to report earnings on November 5, 2026.

What was Boundless Bio, Inc.'s most recent earnings date?

Boundless Bio, Inc. (BOLD) last reported earnings on August 7, 2026.

Where is Boundless Bio, Inc. stock listed?

Boundless Bio, Inc. (BOLD) is listed on Nasdaq.